DTE

31.41

-4.59%↓

IBE

14.405

-4.41%↓

EOAN

13.57

-2.9%↓

RWE

31.31

-2.85%↓

VER1

61.85

-4.18%↓

DTE

31.41

-4.59%↓

IBE

14.405

-4.41%↓

EOAN

13.57

-2.9%↓

RWE

31.31

-2.85%↓

VER1

61.85

-4.18%↓

DTE

31.41

-4.59%↓

IBE

14.405

-4.41%↓

EOAN

13.57

-2.9%↓

RWE

31.31

-2.85%↓

VER1

61.85

-4.18%↓

DTE

31.41

-4.59%↓

IBE

14.405

-4.41%↓

EOAN

13.57

-2.9%↓

RWE

31.31

-2.85%↓

VER1

61.85

-4.18%↓

DTE

31.41

-4.59%↓

IBE

14.405

-4.41%↓

EOAN

13.57

-2.9%↓

RWE

31.31

-2.85%↓

VER1

61.85

-4.18%↓

Search

STRATEC Biomedical AG

Gesloten

22.2 -1.99

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

20.65

Max

23.45

Belangrijke statistieken

By Trading Economics

Inkomsten

-2.9M

549K

Verkoop

-11M

57M

K/W

Sectorgemiddelde

29.695

28.692

Dividendrendement

2.16

Winstmarge

0.959

Werknemers

1,462

EBITDA

-3.3M

7.1M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+71.67% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

2.16%

3.67%

Volgende Winsten

29 apr 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

296M

Vorige openingsprijs

24.19

Vorige sluitingsprijs

22.2

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

STRATEC Biomedical AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

7 apr 2025, 23:56 UTC

Top Nieuws

Australian Consumer Confidence Firms Despite Market Falls

7 apr 2025, 23:45 UTC

Populaire aandelen

Stocks to Watch: CVS Health, UnitedHealth Group, Spire Global, Pacira BioSciences

7 apr 2025, 21:36 UTC

Belangrijke Marktbewegers

Medicare Insurer Shares Rise on Plans for Higher Payment Rates

7 apr 2025, 21:11 UTC

Belangrijke Marktbewegers

Broadcom Authorizes $10 Billion Share Repurchase Program

7 apr 2025, 20:25 UTC

Winsten
Acquisities, Fusies, Overnames

Levi Strauss Posts 1Q Revenue Growth, Backs Guidance Amid 'Uncertain Environment'

7 apr 2025, 23:48 UTC

Marktinformatie

Nikkei May Rise After Recent Selloffs -- Market Talk

7 apr 2025, 23:47 UTC

Marktinformatie

Gold Edges Lower Amid More Cautious Near-Term Outlook -- Market Talk

7 apr 2025, 21:43 UTC

Marktinformatie

Oil Producers Choosing Returns Over Growth In Tariffs Fallout -- Market Talk

7 apr 2025, 21:37 UTC

Marktinformatie

Canada Faces Financial Crisis-Like Symptoms That Rate Cuts Won't Cure -- Market Talk

7 apr 2025, 21:32 UTC

Acquisities, Fusies, Overnames

Infineon: All-Cash Transaction to Be Financed From Existing Liquidity and Additional Debt >IFX.FF

7 apr 2025, 21:32 UTC

Acquisities, Fusies, Overnames

Infineon: Transaction Combines Infineon's Portfolio for Automotive Microcontrollers With Automotive Ethernet Business of Marvell, Accelerating Infineon's System Capabilities for Software-Defined Vehicles >IFX.FF

7 apr 2025, 21:32 UTC

Acquisities, Fusies, Overnames

Infineon: Business Expected to Generate Rev of $225M-$250M in Calendar Yr 2025 With Gross Margin of Around 60% >IFX.FF

7 apr 2025, 21:32 UTC

Acquisities, Fusies, Overnames

Infineon: Enters Agreement for Acquisition of Marvell Technology's Automotive Ethernet Business for US$2.5 B >IFX.FF

7 apr 2025, 21:31 UTC

Top Nieuws

Apple Plans to Source More iPhones From India as Potential Tariff Fix -- Update

7 apr 2025, 21:29 UTC

Top Nieuws

PNC Names Former BlackRock Star Mark Wiedman as President -- WSJ

7 apr 2025, 21:28 UTC

Acquisities, Fusies, Overnames

Infineon Further Strengthens Its Number One Position In Automotive Microcontrollers And Boosts Systems Capabilities For Software-defined Vehicles With Acquisition Of Marvell's Automotive Ethernet Business >IFNNY MRVL

7 apr 2025, 21:21 UTC

Top Nieuws

Defense Stocks Can't Escape the Trade War. Expect to Hear This Term. -- Barrons.com

7 apr 2025, 21:18 UTC

Top Nieuws
Winsten

Levi Strauss Trying to Mitigate Tariff Impact on Consumer; Company Grows Revenue -- Update

7 apr 2025, 21:17 UTC

Winsten

Levi Sees U.S. Consumer 'Generally Resilient,' CFO Says

7 apr 2025, 21:17 UTC

Winsten

Levi Looking at Cost-Related Opportunities, Pricing Changes as Part of Response, CFO Says

7 apr 2025, 21:16 UTC

Winsten

Levi Strauss Sets Up Task Force to Understand Implications of Trump's Tariffs, CFO Singh Says

7 apr 2025, 21:16 UTC

Top Nieuws

What to Know About Trump's Latest Tariffs -- 3rd Update

7 apr 2025, 21:15 UTC

Acquisities, Fusies, Overnames

Marvell to Sell In-Vehicle Network Portfolio for $2.5B

7 apr 2025, 21:14 UTC

Top Nieuws

PNC Taps Ex-BlackRock Star Mark Wiedman as President -- WSJ

7 apr 2025, 21:06 UTC

Top Nieuws
Acquisities, Fusies, Overnames

Trump Orders New Review of Nippon-U.S. Steel Merger -- 3rd Update

7 apr 2025, 20:59 UTC

Top Nieuws

U.S. Stock Meltdown Gives Way to Global Rout -- WSJ

7 apr 2025, 20:56 UTC

Belangrijke Marktbewegers

Broadcom Authorizes $10B Share Repurchase Program

7 apr 2025, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

7 apr 2025, 20:33 UTC

Top Nieuws

Markets Swing Wildly After Trump Holds His Ground on Tariff Plan -- WSJ

7 apr 2025, 20:29 UTC

Top Nieuws

Tesla Stock Tanks Again. Price Target Slashed 43% Amid Musk's 'Brand Crisis Tornado.' -- Barrons.com

Peer Vergelijking

Prijswijziging

STRATEC Biomedical AG Prognose

Koersdoel

By TipRanks

71.67% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 40 EUR  71.67%

Hoogste 41 EUR

Laagste 39 EUR

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor STRATEC Biomedical AG - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

3 ratings

1

Buy

2

Hold

0

Sell

Technische score

By Trading Central

23.05 / 25.5Steun & Weerstand

Korte Termijn

Bearish Evidence

Gemiddeld Termijn

Very Strong Bearish Evidence

Lange Termijn

Bearish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over STRATEC Biomedical AG

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.